DOJ Announces National Rapid Response Strike Force
Earlier this year, at the same time the United States Department of Justice (DOJ) announced the largest health care fraud and…
Monthly Publications
In Depth
Subscribe Now
In Depth
coverage of timely
Life Science
Compliance issues
Subscribe Now
Yearly Archives
2020
PhRMA Files Motion for Restraining Order and Preliminary Injunction in MFN…
On December 10, 2020, the Pharmaceutical Research and Manufacturers of America (PhRMA), the Association of Community Cancer…
ACCME Announces New Standards for Integrity and Independence for Accredited…
Yesterday, the Accreditation Council for Continuing Medical Education (ACCME) announced new Standards for Integrity and…
Lawsuit Filed Challenging the Legality of the Most Favored Nation Interim…
On December 4, 2020, the Pharmaceutical Research and Manufacturers of America (PhRMA) – along with the Association of Community…
HHS Issues Policy Statements and RFI on Rulemaking and Transparency
On November 24, 2020, the Department of Health and Human Services (HHS) announced two policy statements and a request for…
PhRMA Files Suit to Stop Drug Importation from Canada
On Monday, November 23, 2020, the Pharmaceutical Research and Manufacturers of America (PhRMA), along with the Partnership for…
Patient and Provider Groups Call on Congress to Stop CMS Policy
Recently, the All Copays Count Coalition (ACCC) sent a letter to House of Representatives Speaker Nancy Pelosi and Minority Leader…
FDA Announces End of Unapproved Drugs Initiative
On Friday, November 20, 2020, the United States Food and Drug Administration (FDA) announced it would end the Unapproved Drugs…
Final Rules Published on Stark Law and Anti-Kickback Statute
Along with the two other rules that we previously wrote about (the MFN rule and the AKS safe harbor rule), on November 20, 2020,…
FDA Proposes Clarifying Intended Use Regulations
Earlier this year, the United States Food and Drug Administration (FDA) published a proposed rule that would amend its “intended…